01244 3D MEDICINES
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.45X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 1.1% | Net Margin | N/A |
| Total Debt/Equity | 25.6% | Return on Equity | N/A |
| Price/Book | 1.59X | Return on Assets | N/A |
| (HKD 4.100) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -197.61 | -194.26 | -578.32 | -1,148.50 | -1,754.04 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -1.7 | +66.4 | +49.7 | +34.5 | -132.6 |
| Earnings Per Share (HKD) | -0.805 | -0.793 | -2.531 | -25.248 | -44.917 |
| Earnings Per Share Growth (%) | -1.5 | +68.7 | +90.0 | +43.8 | -171.6 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.573 | 3.234 | 3.999 | 4.136 | N/A |
| Auditors' Opinion | N/A | Unqualified # | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 356.088 | 445.647 | -20.1 | 634.949 |
| Operating Result | -184.943 | -199.378 | -7.2 | -562.466 |
| Profit Before Taxation | -184.943 | -199.378 | -7.2 | -562.466 |
| Taxation | -0.055 | 0 | N/A | 0.055 |
| Profit /( Loss) After Taxation | -184.888 | -199.378 | -7.3 | -562.521 |
| Minority Interests | -7.357 | -16.715 | -56.0 | -37.824 |
| Net Profit | -177.531 | -182.663 | -2.8 | -524.697 |
| Earnings Per Share () | -0.8050 | -0.7930 | +1.5 | -2.5313 |
| Announcement Date | 2026-03-31 | 2025-03-31 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
